This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
The trial objective was to compare the performance and animal health parameters of pigs raised according to one of 3 antibiotic (AB) protocols: standard AB medication consisting of mass treatment on days 4 and 21 and judicious AB therapy given therapeutically thereafter as group medication in water and feed or by individual injection (group T1, N = 702); modified AB medication identical to group T1 but with mass treatment only on day 4 and without subsequent therapeutic feed medication (group T2, N = 675); or an antibiotic-free (ABF) regimen (group T3, N = 702). All pigs were vaccinated with a modified-live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine 3 days after weaning. Using a seeder pig model to mimic endemic field infection dynamics, pigs were contact-challenged with virulent PRRSV lineage 1 strain 174 four weeks after vaccination. At finishing, average daily gain (ADG) and mean feed conversion ratio (FCR) were significantly better (p ≤ 0.05) for the T1 and T2 groups compared to the T3 group. There were no significant differences in post-weaning ADG and FCR between the T1 and T2 groups. Mortality and removals significantly favored (p ≤0.05) the T1 and T2 groups (20.94% and 24.89%, respectively) versus the T3 group (57.98%). Net revenue per pig was $105.43, $98.79, and $33.81 for the T1, T2 and T3 groups, respectively. Under the conditions of this study, these results indicate that in a PRRSV-endemic setting involving bacterial co-infections, an ABF production strategy may leave pigs at considerable risk of exposure to severe clinical disease and that judicious use of antibiotics can significantly improve animal health.
In 2014, it was first reported that pigs could become infected with porcine epidemic diarrhoea virus (PEDV) following consumption of contaminated feed via natural feeding behaviour (Dee et al., 2014).Since that time, similar observations have been reported for Seneca virus A (SVA), porcine reproductive and respiratory syndrome virus (PRRSV) and African swine fever virus (ASFV) (Dee et al., 2020a;Niederwerder et al., 2019,). These and other studies have also confirmed that certain feed ingredients, that is, soy-based products, are protective to viruses and enhance their survival for extended periods under simulated conditions of transoceanic shipping. (Dee
The hypothesis that feed ingredients could serve as vehicles for the
transport and transmission of viral pathogens was first validated under
laboratory conditions. To bridge the gap from the laboratory to the
field, this current project tested whether three significant viruses of
swine could survive in feed ingredients during long-distance commercial
transport across the continental US. One-metric ton totes of soybean
meal (organic and conventional) and complete feed were spiked with a 10
mL mixture of PRRSV 174, PEDV, and SVA and transported for 23 days in a
commercial semi-trailer truck, crossing 29 states, and 10,183 km.
Samples were tested for the presence of viral RNA by PCR, and for viable
virus in soy-based samples by swine bioassay and in complete feed
samples by natural feeding. Viable PRRSV, PEDV, and SVA were detected in
both soy products and viable PEDV and SVA in complete feed. These
results provide the first evidence that viral pathogens of pigs can
survive in representative volumes of feed and feed ingredients during
long-distance commercial transport across the continental US.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.